/product/antibody-drug-conjugates-adc-seattle-genetics-inc-nasdaq-2001-6725.html

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Product › Details

antibody-drug conjugates (ADC) technology

Products Next higher product group drug development technology
Period Status  unspecified existent
Organisation Organisation Seattle Genetics Inc. (Nasdaq: SGEN)
  Today Seagen Inc. (Nasdaq: SGEN)
  Group Pfizer (Group)
     

   
Record changed: 2024-06-02

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for antibody-drug conjugates (ADC) technology


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px




» top